경영·경제 질문은 AI 비서에게,
무엇이든 물어보세요.
로그인 후 질문을 입력해주세요
소개영상보기
Public Health
Hair Loss Recognized as Disease from Follicle Damage
In recent academic discourse, there is growing recognition of hair loss as a disease of modern people. Getty Images Bank After President Lee Jae-myung stated during the Ministry of Health and Welfare’s year-end 2025 policy briefing that “hair loss is a matter of survival,” controversy has reignited in political circles over whether hair loss treatment should be covered by the National Health Insur
2026.02.02
MedTech
Celltrion Internalizes Hyaluronidase SC Formulation Technology
2026.02.02
MedTech
OLED “Hair-Loss Cap” Claims 92% Cell Aging Cut
2026.02.01
MedTech
Korean Team Develops Light-Based Cancer Cell Therapy
2026.02.06
Global Business
Korea United Pharm speeds Vietnam push, targets double cancer drug sales
2026.02.05
Recent Articles
-
MedTechTRM Korea Launches Symani Microsurgery Training CenterPhoto provided by TRM Korea TRM Korea obtained approval from the Ministry of Food and Drug Safety (MFDS) on the 30th of last month for the ultra-microsurgical robot “Symani,” declaring a digital transformation in the domestic microsurgical reconstruction field. The MFDS cited “reduction of surgical2026.02.06 -
MedTechKorean Team Develops Light-Based Cancer Cell TherapyA research team from the Department of Chemistry at Korea University has developed a new phototherapy technology that can kill cancer cells simply by exposure to light. On the 5th, Korea University announced that the team led by Professors Kim Jong-seung, Woo Han-young, and Kwak Kyung-won of the Dep2026.02.06
-
Global BusinessKorea United Pharm speeds Vietnam push, targets double cancer drug salesFrom left: Professor Nguyen Minh Duc, Ngo Duc Vinh, CEO of BIONAM, Kang Duk-young, CEO of Korea United Pharm Inc., Vice President Kim Gwi-ja, and Executive Director Yang Jin-young Korea United Pharm Inc. announced on the 5th that it recently held a strategic meeting with its local Vietnamese partner2026.02.05
-
AI HealthcareChosun University Advances Digital Brainwave Map ProjectProfessor Kim Jung-su (center) of the Department of Biomedical Science at Chosun University, who gave a lecture on the theme of the “Spectrum of Aging” at the Seoul Senior Forum held in Gochang, Jeollabuk-do last year, poses for a commemorative photo with students. Provided by Chosun University The2026.02.04 -
AI HealthcareCM Hospital Adopts Daewoong AI Bed Monitoring System ‘Think’Exterior view of CM Hospital, a general hospital specializing in joints. Provided by CM Hospital CM Hospital, a general hospital specializing in joints located in Yeongdeungpo-gu, Seoul, announced on the 4th that it has adopted Daewoong Pharmaceutical’s artificial intelligence (AI)-based smart ward2026.02.04 -
AI HealthcareStartup-ing: Mediplexus Aims to Lead Full Clinical Data CROWhen researching and developing new drugs or biotechnology, Contract Research Organizations (CROs) play a critical role. They handle the entire sequence of procedures, including subject selection and overall study design, patient recruitment and experimentation, data analysis, and submission of appr2026.02.04 -
MedTechKwangdong, MSD Korea to Co-Market Adult Pneumococcal VaccineKwangdong Pharmaceutical announced on the 4th that it has partnered with MSD Korea to jointly market “Capvaxive®,” a 21-valent pneumococcal conjugate vaccine for adults, in the domestic market. The two companies plan to begin full-scale joint marketing from the time of the vaccine’s launch in the fi2026.02.04 -
Public HealthSamsung Biologics, CEPI Partner on Pandemic Vaccine ProductionAt the signing ceremony held on the 3rd, Richard Hatchett, CEO of CEPI (left), and John Rim, CEO of Samsung Biologics, pose for a commemorative photograph. Samsung Biologics Samsung Biologics announced on the 4th that it has signed a Vaccine Manufacturing Facilities Network (VMFN) partnership agreem2026.02.04 -
AI HealthcareKakao Healthcare, Novo Nordisk Partner on Obesity App SupportKakao Healthcare announced on the 3rd that it has introduced an “obesity patient support service” to its AI-based mobile health management solution “PASTA” app in cooperation with Novo Nordisk Pharma Korea.This new service targets patients prescribed obesity treatments and aims to establish a full-c2026.02.03 -
MedTechAlteogen Sees Record 2025 Margin Despite 2% RoyaltyAlteogen headquarters Alteogen announced through a disclosure on the 2nd that it posted provisional 2024 results of KRW 202.1 billion in revenue and KRW 114.8 billion in operating profit last year. Compared with the previous year, revenue increased by 117% and operating profit grew by 275%, marking2026.02.02
